Earnings Scheduled For March 27, 2026

• Instil Bio (NASDAQ:TIL) is expected to report earnings for its fourth quarter.

• BioXcel Therapeutics (NASDAQ:BTAI) is projected to report quarterly loss at $0.52 per share on revenue of $142 thousand.

• Legence (NASDAQ:LGN) is expected to report quarterly earnings at $0.02 per share on revenue of $618.01 million.

• Werewolf Therapeutics (NASDAQ:HOWL) is likely to report quarterly loss at $0.34 per share on revenue of $600 thousand.

• Humacyte (NASDAQ:HUMA) is estimated to report quarterly loss at $0.13 per share on revenue of $1.44 million.

• Autolus Therapeutics (NASDAQ:AUTL) is projected to report quarterly loss at $0.38 per share on revenue of $23.24 million.

• SBC Medical Group Holding (NASDAQ:SBC) is likely to report quarterly earnings at $0.12 per share on revenue of $46.06 million.

• Yunji (NASDAQ:YJ) is likely to report earnings for its Fiscal Year 2025.

• Huize Holding (NASDAQ:HUIZ) is estimated to report earnings for its Fiscal Year 2025.

• 51 Talk Online Education (AMEX:COE) is likely to report earnings for its fourth quarter.

• Kopin (NASDAQ:KOPN) is projected to report quarterly loss at $0.01 per share on revenue of $11.65 million.

• LM Funding America (NASDAQ:LMFA) is expected to report quarterly loss at $0.45 per share on revenue of $2.80 million.

• TMC The Metals Co (NASDAQ:TMC) is projected to report earnings for its fourth quarter.

• Super League Enterprise (NASDAQ:SLE) is projected to report quarterly loss at $2.98 per share on revenue of $3.58 million.

• Origin Materials (NASDAQ:ORGN) is likely to report earnings for its fourth quarter.

This article was generated by Benzinga's automated content engine and reviewed by an editor.